Equity, diversity and inclusion

We actively work to challenge and remove barriers to access, experience, and outcomes – ensuring that all our staff and, regardless of their background, have the opportunity to thrive.   We track representation across all levels of REACT and take decisive …

Environmental sustainability

Each of our three partner institutions has developed ambitious sustainability strategies, underpinned by substantial investment and a shared commitment to climate action. As signatories to the Race to Zero for Universities and Colleges , they have pledged …

Code of conduct

The code of conduct is being co-created by staff and students working across REACT. This will ensure that the principles, expectations and values it sets out reflect the diverse perspectives and experiences of our centre community. Through this approach, …

Career development

As the field of gene therapies to stimulate cardiac repair is emerging and rapidly evolving, specialist training opportunities remain limited.  Through REACT, we address this gap by convening leading experts from the UK and internationally to deliver a …

Professor Paul Riley

Paul is BHF Professor of Regenerative Medicine and Director of the Institute of Developmental and Regenerative Medicine at the University of Oxford. His research interests span cardiovascular developmental biology and modelling congenital heart disease, …

Target discovery

REACT members have pioneered the concept that small non-coding RNAs, mRNAs and cDNAs can be identified by screening and then administered to achieve cardiac regeneration. Therapeutic targets include stimulating cardiomyocyte proliferation, inducing the …

Cardiac delivery

We aim to achieve cardiac-specific targeting of vectors and nanoparticle-delivered nucleic acid medicines to minimise adverse effects and allow for effective, inducible and/or regulated expression of single or multiple target therapeutic nucleic acids.  …

Clinical translation

A comprehensive array of pre-clinical models will be utilised to test therapeutic leads generated by REACT. Existing targets will be fast tracked for safety and efficacy assessment in models of chronic heart failure conditions, and then prioritised for …

Studentships

There are not currently any REACT PhD studentships accepting applications at King's College London, the University of Edinburgh or the University of Oxford. Check back soon for …

Events

The REACT symposium is our annual meeting for members, collaborators and guests across the broad network of the MRC/BHF CoRE in Advanced Cardiac Therapies. Plans are now underway for the 2026 event in London. More information is available on our symposium …